Conventionally, stroke management protocols recommend the administration of tissue plasminogen activator (t-PA) before CTA, and the CTA-Alberta Stroke Program Early CT Score (ASPECTS) can serve as a prognostic tool to predict the therapeutic efficacy of intravascular interventions in patients with stroke (39). The gene discussed is PLAT; the disease is Stroke.